Predicting human immunodeficiency virus type 1-positive sera by using two enzyme immunoassay kits in a parallel...

Area of Science:

• Immunology
• Virology
• Diagnostic Medicine

Background:

• Accurate screening for human immunodeficiency virus type 1 (HIV-1) antibodies is crucial for public health.
• Populations with heterogeneous risk factors present challenges for diagnostic test interpretation.
• Enzyme immunoassay (EIA) kits are standard tools for initial HIV-1 antibody screening.

Purpose of the Study:

• To compare the efficiency of two distinct algorithms for screening sera for HIV-1 antibodies.
• To evaluate diagnostic performance based on specificity and positive predictive value (PPV) in a diverse population.
• To determine the optimal algorithm for reliable identification of true-positive HIV-1 antibody samples.

Main Methods:

• Algorithm 1: Single enzyme immunoassay (EIA) kit screening for all sera.
• Algorithm 2: Parallel screening of each sample using two different EIA kits.
• Evaluation criteria: Specificity and positive predictive value (PPV) for true-positive sera.

Main Results:

• Single EIA (Algorithm 1) yielded 98.6% specificity and 69.3% PPV.
• Dual EIA (Algorithm 2), requiring reactivity in both kits, achieved 100% specificity and 100% PPV.
• Dual EIA (Algorithm 2), including one reactive and one equivocal result, showed 99.97% specificity and 99.4% PPV.

Conclusions:

• A parallel dual enzyme immunoassay (EIA) algorithm significantly enhances diagnostic accuracy for HIV-1 antibody screening compared to a single EIA.
• The dual EIA approach, particularly requiring dual reactivity, offers superior specificity and positive predictive value, crucial for minimizing false positives in diverse populations.
• Implementing a dual EIA strategy is recommended for more reliable HIV-1 antibody detection, especially in settings with varied risk factors.